Literature DB >> 7992852

Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.

H Ksiezak-Reding1, K Morgan, L A Mattiace, P Davies, W K Liu, S H Yen, K Weidenheim, D W Dickson.   

Abstract

Corticobasal degeneration (CBD) is a neurodegenerative disorder associated with extensive cytoskeletal abnormalities. These include tau-positive neuropil threads and grains, ballooned or swollen neurons, neurofibrillary tangles, and glial inclusions. Given the presence of tau-positive structures in CBD, we investigated whether abnormalities in tau proteins associated with CBD were similar to those in Alzheimer's disease (AD). Fractions of abnormal tau proteins were isolated as Sarkosyl-insoluble pellets. By electron microscopic examination, the fraction from CBD contained twisted filaments that differed from paired helical filaments of AD. In CBD, filaments were shorter in length, rarely longer than 400 nm, 10 to 20% wider in the maximum and minimum widths (26 to 28 nm and 13 to 14 nm, respectively), and the periodic twist (169 to 202 nm) was twice as long as that in AD. Immunogold labeling with a panel of tau-reactive antibodies (Alz 50, Tau 14, AH-1, E-11, PHF-1, and Tau 46) showed no apparent differences in the pattern of tau immunoreactivity between filaments of CBD and AD. Western blots revealed that polypeptides of abnormal tau were present in both fractions; however, only two polypeptides (68 and 64 kd) were present in CBD as compared with three (68, 64, and 60 kd) in AD. Both of these polypeptides were reactive with additional antibodies (E-9, Tau-1 after dephosphorylation, AT8, and NP8). Only one polypeptide (68 kd) bound an antibody to adult-specific tau sequence encoded by exon 2, but neither was reactive with antibodies to adult-specific sequences encoded by exons 3 and 10. The results suggest that abnormalities in the number and heterogeneity of isoforms of tau may be one of the factors contributing to ultrastructural differences in pathological filaments of CBD and AD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7992852      PMCID: PMC1887493     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

1.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly.

Authors:  D W Cleveland; S Y Hwo; M W Kirschner
Journal:  J Mol Biol       Date:  1977-10-25       Impact factor: 5.469

2.  Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau.

Authors:  M Goedert; M G Spillantini; R Jakes
Journal:  Neurosci Lett       Date:  1991-05-27       Impact factor: 3.046

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations.

Authors:  H C Powell; G W London; P W Lampert
Journal:  J Neuropathol Exp Neurol       Date:  1974-01       Impact factor: 3.685

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Immunological and conformation characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease.

Authors:  E Lang; G I Szendrei; V M Lee; L Otvos
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

7.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

8.  Amino acid residues 226-240 of tau, which encompass the first Lys-Ser-Pro site of tau, are partially phosphorylated in Alzheimer paired helical filament-tau.

Authors:  W K Liu; D W Dickson; S H Yen
Journal:  J Neurochem       Date:  1994-03       Impact factor: 5.372

9.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue.

Authors:  T Yamada; P L McGeer; E G McGeer
Journal:  Neurosci Lett       Date:  1992-01-20       Impact factor: 3.046

10.  Distribution and ultrastructure of Alzheimer's neurofibrillary tangles in postencephalitic Parkinsonism of Economo type.

Authors:  T Ishii; Y Nakamura
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more
  56 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Tau protein expression in adult bovine oligodendrocytes: functional and pathological significance.

Authors:  Hanna Ksiezak-Reding; Muhammad Farooq; Liang-sheng Yang; Dennis W Dickson; Patrizia LoPresti
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

3.  Characterization of tau fibrillization in vitro.

Authors:  Shaohua Xu; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

4.  Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.

Authors:  Maiko Ono; Naruhiko Sahara; Katsushi Kumata; Bin Ji; Ruiqing Ni; Shunsuke Koga; Dennis W Dickson; John Q Trojanowski; Virginia M-Y Lee; Mari Yoshida; Isao Hozumi; Yasumasa Yoshiyama; John C van Swieten; Agneta Nordberg; Tetsuya Suhara; Ming-Rong Zhang; Makoto Higuchi
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

5.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

Review 6.  The tauopathies: toward an experimental animal model.

Authors:  M Goedert; M Hasegawa
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

7.  Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation.

Authors:  Solomiia Boyko; Krystyna Surewicz; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

Review 8.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

9.  RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

Authors:  Isaac Bishof; Eric B Dammer; Duc M Duong; Sean R Kundinger; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  J Biol Chem       Date:  2018-05-25       Impact factor: 5.157

10.  Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

Authors:  M Pérez; J M Valpuesta; E M de Garcini; C Quintana; M Arrasate; J L López Carrascosa; A Rábano; J García de Yébenes; J Avila
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.